IAC Inc.
For the period ended Sep 30, 2025. Filed Nov 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 3, 2025
PPLI$42.08+2.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Shareholders' Equity
Three and nine months ended September 30, 2025
| Redeemable Noncontrolling Interests · Common Stock, $0.0001 par value · Class B common stock, $0.0001 par value · Additional Paid-in-Capital · Accumulated Deficit · Accumulated Other Comprehensive Loss · Treasury Stock · Total IACShareholders' Equity · NoncontrollingInterests · Total Shareholders' Equity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ · Shares · $ · Shares | ||||||||||||
| (In thousands) | ||||||||||||
| Balance at June 30, 2025 | $25,279 | $8 | 82,946 | $1 | 5,789 | $5,920,478 | $(544,327) | $(11,102) | $(453,966) | $4,911,092 | $26,411 | $4,937,503 |
| Net earnings (loss) | 156 | — | — | — | — | — | (21,879) | — | — | (21,879) | (14) | (21,893) |
| Other comprehensive loss, net of income taxes | — | — | — | — | — | — | — | (777) | — | (777) | — | (777) |
| Stock-based compensation expense | — | — | — | — | — | 16,639 | — | — | — | 16,639 | 353 | 16,992 |
| Issuance of common stock pursuant to stock-based awards, net of withholding taxes | — | — | 293 | — | — | (12,734) | — | — | — | (12,734) | — | (12,734) |
| Purchase of IAC treasury stock | — | — | — | — | — | — | — | — | (100,882) | (100,882) | — | (100,882) |
| Adjustment of noncontrolling interests to redemption amount | (156) | — | — | — | — | 156 | — | — | — | 156 | — | 156 |
| Adjustment to the liquidation value of Vivian Health preferred shares | — | — | — | — | — | (1,178) | — | — | — | (1,178) | 1,178 | — |
| Other | — | — | — | — | — | 49 | — | — | — | 49 | — | 49 |
| Balance at September 30, 2025 | $25,279 | $8 | 83,239 | $1 | 5,789 | $5,923,410 | $(566,206) | $(11,879) | $(554,848) | $4,790,486 | $27,928 | $4,818,414 |
| Balance at December 31, 2024 | $25,415 | $8 | 84,831 | $1 | 5,789 | $6,380,700 | $(538,974) | $(11,396) | $(252,441) | $5,577,898 | $701,075 | $6,278,973 |
| Net earnings (loss) | 244 | — | — | — | — | — | (27,232) | — | — | (27,232) | 1,316 | (25,916) |
| Other comprehensive (loss) income, net of income taxes | — | — | — | — | — | — | — | (105) | — | (105) | 433 | 328 |
| Stock-based compensation expense | — | — | — | — | — | 13,270 | — | — | — | 13,270 | 2,145 | 15,415 |
| Issuance of common stock pursuant to stock-based awards, net of withholding taxes | — | — | 1,408 | — | — | (57,913) | — | — | — | (57,913) | — | (57,913) |
| Forfeiture of IAC's former CEO's restricted common stock award | — | — | (3,000) | — | — | — | — | — | — | — | — | — |
| Withholding taxes paid on IAC's transfer of Angi Inc. Class B shares to its former CEO | — | — | — | — | — | (9,347) | — | — | — | (9,347) | — | (9,347) |
| Issuance of Angi Inc. Class A common stock pursuant to stock-based awards, net of withholding taxes, prior to the Distribution | — | — | — | — | — | (8,264) | — | 4 | — | (8,260) | 3,688 | (4,572) |
| Purchase of IAC treasury stock | — | — | — | — | — | — | — | — | (302,407) | (302,407) | — | (302,407) |
| Purchase of Angi Inc. treasury stock prior to the Distribution | — | — | — | — | — | (10,688) | — | — | — | (10,688) | — | (10,688) |
| Adjustment of noncontrolling interests to redemption amount | (347) | — | — | — | — | 347 | — | — | — | 347 | — | 347 |
| Adjustment to the liquidation value of Vivian Health preferred shares | — | — | — | — | — | (2,198) | — | — | — | (2,198) | 2,198 | — |
| Distribution of IAC's investment in Angi Inc. | — | — | — | — | — | (1,065,612) | — | (382) | — | (1,065,994) | — | (1,065,994) |
| Elimination of Angi Inc. noncontrolling interest | — | — | — | — | — | 682,927 | — | — | — | 682,927 | (682,927) | — |
| Other | (33) | — | — | — | — | 188 | — | — | — | 188 | — | 188 |
| Balance at September 30, 2025 | $25,279 | $8 | 83,239 | $1 | 5,789 | $5,923,410 | $(566,206) | $(11,879) | $(554,848) | $4,790,486 | $27,928 | $4,818,414 |
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY
Three and nine months ended September 30, 2024
| Redeemable Noncontrolling Interests · Common Stock, $0.0001 par value · Class B common stock, $0.0001 par value · Additional Paid-in-Capital · (Accumulated Deficit) Retained Earnings · Accumulated Other Comprehensive (Loss) Income · Treasury Stock · Total IACShareholders' Equity · NoncontrollingInterests · Total Shareholders' Equity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ · Shares · $ · Shares | ||||||||||||
| (In thousands) | ||||||||||||
| Balance at June 30 2024 | $29,132 | $8 | 84,683 | $1 | 5,789 | $6,363,548 | $(96,278) | $(6,473) | $(252,441) | $6,008,365 | $687,713 | $6,696,078 |
| Net earnings (loss) | 832 | — | — | — | — | — | (243,719) | — | — | (243,719) | 5,442 | (238,277) |
| Other comprehensive (loss) income, net of income taxes | — | — | — | — | — | — | — | (3,142) | — | (3,142) | 632 | (2,510) |
| Stock-based compensation expense | — | — | — | — | — | 18,209 | — | — | — | 18,209 | 11,336 | 29,545 |
| Issuance of common stock pursuant to stock-based awards, net of withholding taxes | — | — | 140 | — | — | (5,822) | — | — | — | (5,822) | — | (5,822) |
| Issuance of Angi Inc. common stock pursuant to stock-based awards, net of withholding taxes | — | — | — | — | — | 3,613 | — | 7 | — | 3,620 | (4,529) | (909) |
| Purchase of Angi Inc. treasury stock | — | — | — | — | — | (7,588) | — | — | — | (7,588) | — | (7,588) |
| Purchase of noncontrolling interests | — | — | — | — | — | (11,296) | — | — | — | (11,296) | (4,723) | (16,019) |
| Adjustment of noncontrolling interests to redemption amount | (27) | — | — | — | — | 27 | — | — | — | 27 | — | 27 |
| Adjustment to the liquidation value of Vivian Health preferred shares | — | — | — | — | — | 1,356 | — | — | — | 1,356 | (1,356) | — |
| Other | (1,258) | — | — | — | — | 34 | — | — | — | 34 | — | 34 |
| Balance at September 30, 2024 | $28,679 | $8 | 84,823 | $1 | 5,789 | $6,362,081 | $(339,997) | $(9,608) | $(252,441) | $5,760,044 | $694,515 | $6,454,559 |
| Balance at December 31, 2023 | $33,378 | $8 | 84,465 | $1 | 5,789 | $6,340,312 | $923 | $(10,942) | $(252,441) | $6,077,861 | $677,142 | $6,755,003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net earnings (loss) | 741 | — | — | — | — | — | (340,920) | — | — | (340,920) | 6,239 | (334,681) |
| Other comprehensive income, net of income taxes | — | — | — | — | — | — | — | 1,323 | — | 1,323 | 437 | 1,760 |
| Stock-based compensation expense | — | — | — | — | — | 58,144 | — | — | — | 58,144 | 32,448 | 90,592 |
| Issuance of common stock pursuant to stock-based awards, net of withholding taxes | — | — | 358 | — | — | (14,637) | — | — | — | (14,637) | — | (14,637) |
| Issuance of Angi Inc. common stock pursuant to stock-based awards, net of withholding taxes | — | — | — | — | — | 5,868 | — | 11 | — | 5,879 | (11,531) | (5,652) |
| Purchase of Angi Inc. treasury stock | — | — | — | — | — | (25,772) | — | — | — | (25,772) | — | (25,772) |
| Purchase of noncontrolling interests | — | — | — | — | — | (11,296) | — | — | — | (11,296) | (4,723) | (16,019) |
| Adjustment of noncontrolling interests to redemption amount | (3,869) | — | — | — | — | 3,869 | — | — | — | 3,869 | — | 3,869 |
| Adjustment to the liquidation value of Vivian Health preferred shares | — | — | — | — | — | 5,497 | — | — | — | 5,497 | (5,497) | — |
| Other | (1,571) | — | — | — | — | 96 | — | — | — | 96 | — | 96 |
| Balance at September 30, 2024 | $28,679 | $8 | 84,823 | $1 | 5,789 | $6,362,081 | $(339,997) | $(9,608) | $(252,441) | $5,760,044 | $694,515 | $6,454,559 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.